CONCLUSIONS
•
RT to N+ pelvic lymph nodes – emerging data but no
RCT – extrapolation of data
•
Neoadjuvant ADT to reduce LN – treat microscopic
disease
•
EBRT can now be given with reduced toxicity
•
Role of chemotherapy
•
Role of Surgery